Universität zu Köln

Journal Article

Jawhar, Mohamad, Naumann, Nicole, Schwaab, Juliana, Baurmann, Herrad, Casper, Jochen, Dietze, Lutz, Doehner, Konstanze, Haenel, Annette, Lathan, Bernd, Link, Hartmut, Lotfi, Sina, Maywald, Ole, Mielke, Stephan ORCID: 0000-0002-8325-9215, Mueller, Lothar, Platzbecker, Uwe, Pruemmer, Otto, Thomssen, Henrike, Toepelt, Karin, Panse, Jens, Vieler, Tom, Hofmann, Wolf-Karsten, Haferlach, Torsten, Haferlach, Claudia, Fabarius, Alice, Hochhaus, Andreas, Cross, Nicholas C. P., Reiter, Andreas and Metzgeroth, Georgia (2017). Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase. Ann. Hematol., 96 (9). S. 1463 - 1471. NEW YORK: SPRINGER. ISSN 1432-0584

Koschmieder, Steffen, Isfort, Susanne, Heidel, Florian H., Hochhaus, Andreas, Becker, Heiko, Jost, Philipp J., Schafhausen, Philippe, Griesshammer, Martin, Wolleschak, Denise, Haenel, Mathias, Goethert, Joachim R., Teichmann, Lino L., Sockel, Katja, Radsak, Markus P., Reiter, Andreas, Doehner, Konstanze, Balleisen, Sebastian, Jaekel, Nadja, von Bubnoff, Nikolas, Stegelmann, Frank, Gezer, Deniz, Kortmann, Maike, Frank, Julia, Hellmich, Martin and Bruemmendorf, Tim H. (2022). Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN). Blood, 140. S. 1790 - 1794. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Koschmieder, Steffen ORCID: 0000-0002-1011-8171, Isfort, Susanne, Wolf, Dominik, Heidel, Florian H., Hochhaus, Andreas, Schafhausen, Philippe, Griesshammer, Martin, Wolleschak, Denise, Platzbecker, Uwe, Doehner, Konstanze, Jost, Philipp J., Parmentier, Stefani, Schaich, Markus, von Bubnoff, Nikolas, Stegelmann, Frank, Maurer, Angela, Crysandt, Martina, Gezer, Deniz, Kortmann, Maike, Franklin, Jeremy, Frank, Julia, Hellmich, Martin and Bruemmendorf, Tim H. (2023). Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group. Ann. Hematol., 102 (2). S. 349 - 359. NEW YORK: SPRINGER. ISSN 1432-0584

Rautenberg, Christina, Stoelzel, Friedrich, Roellig, Christoph, Stelljes, Matthias, Gaidzik, Verena, Lauseker, Michael, Kriege, Oliver, Verbeek, Mareike, Unglaub, Julia Marie, Thol, Felicitas, Krause, Stefan W., Haenel, Mathias, Neuerburg, Charlotte, Vucinic, Vladan, Jehn, Christian-Friedrich, Severmann, Julia, Wass, Maxi, Fransecky, Lars, Chemnitz, Jens, Holtick, Udo, Schaefer-Eckart, Kerstin, Schroeder, Josephine, Kraus, Sabrina, Krueger, William, Kaiser, Ulrich, Scholl, Sebastian, Koch, Kathrin, Henning, Lea, Kobbe, Guido, Haas, Rainer, Alakel, Nael, Roehnert, Maximilian-Alexander, Sockel, Katja, Hanoun, Maher, Platzbecker, Uwe, Holderried, Tobias A. W., Morgner, Anke, Heuser, Michael, Sauer, Tim, Goetze, Katharina S., Wagner-Drouet, Eva, Doehner, Konstanze, Doehner, Hartmut, Schliemann, Christoph, Schetelig, Johannes, Bornhaeuser, Martin, Germing, Ulrich, Schroeder, Thomas and Middeke, Jan Moritz (2021). Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia. Blood Cancer J., 11 (10). LONDON: SPRINGERNATURE. ISSN 2044-5385

Schnaiter, Andrea, Rossi, Marianna, Paschka, Peter, Cazzola, Mario, Doehner, Konstanze, Edelmann, Jennifer, Buehler, Andreas, Kless, Sabrina, Mertens, Daniel, Busch, Raymonde, Mack, Silja, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2012). NOTCH1, SF3B1 and TP53 Mutations in Fludarabine-Refractory CLL Patients Treated with Alemtuzumab: Results From the CLL2H Trial of the Gcllsg. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Stegelmann, Frank, Bangerter, Markus, Heidel, Florian H., Griesshammer, Martin, Hebart, Holger, Hochhaus, Andreas, Koschmieder, Steffen, Moehle, Robert, Reiter, Andreas, Scheid, Christof, Kirschbaum, Rebecca, Reim, Regina, Sutter, Ulrike, Vetter, Katrin, Doehner, Hartmut, Schlenk, Richard F. and Doehner, Konstanze (2015). A Phase-Ib/II Study of Ruxolitinib Plus Pomalidomide in Myelofibrosis. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stegelmann, Frank, Hebart, Holger, Bangerter, Markus, Wolleschak, Denise, Griesshammer, Martin, Koschmieder, Steffen, von Bubnoff, Nikolas ORCID: 0000-0001-9593-8947, Moehle, Robert, Kindler, Thomas, Hochhaus, Andreas, Heidel, Florian H., Reiter, Andreas, Scheid, Christof, Kirschbaum, Rebecca, Reim, Regina, Sutter, Ulrike, Vetter, Katrin, Doehner, Hartmut, Schlenk, Richard F. and Doehner, Konstanze (2016). Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Busch, Raymonde, Schnaiter, Andrea, Paschka, Peter, Rossi, Marianna, Doehner, Konstanze, Zenz, Thorsten, Buehler, Andreas, Winkler, Dirk, Edelmann, Jennifer, Mertens, Daniel, Bullinger, Lars, Kless, Sabrina, Mack, Silja, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Jaeger, Ulrich, Lichter, Peter, Patten, Nancy, Wenger, Michael K., Mendila, Myriam, Fingerle-Rowson, Gunter, Cazzola, Mario, Wendtner, Clemens, Fink, Anna Maria, Fischer, Kirsten, Hallek, Michael and Doehner, Hartmut (2012). Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Stilgenbauer, Stephan, Schnaiter, Andrea, Paschka, Peter, Zenz, Thorsten, Rossi, Marianna ORCID: 0000-0003-1661-1511, Doehner, Konstanze, Buehler, Andreas, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Winkler, Dirk, Tausch, Eugen, Hoth, Patrick, Edelmann, Jennifer, Mertens, Daniel ORCID: 0000-0003-0227-7188, Bullinger, Lars, Bergmann, Manuela, Kless, Sabrina, Mack, Silja, Jaeger, Ulrich, Patten, Nancy, Wu, Lin, Wenger, Michael K., Fingerle-Rowson, Guenter, Lichter, Peter, Cazzola, Mario, Wendtner, Clemens M., Fink, Anna M., Fischer, Kirsten, Busch, Raymonde, Hallek, Michael and Doehner, Hartmut (2014). Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood, 123 (21). S. 3247 - 3255. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020